Physician profile
Thomas Philip Sangiovanni
NPI 1518932896
$2,119,963.19
in general payments reported to CMS, 2019-2025
20 companies · $44K in 2025
The $44K reported for 2025 was more than what 90% of Foot and Ankle Surgery providers received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $355K · 2020: $960K · 2021: $291K · 2022: $206K · 2023: $82K · 2024: $183K · 2025: $44K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $201K · Royalty Or License: $76K · Travel and Lodging: $29K · Food and Beverage: $3,256 · Long Term Medical Supply Or Device Loan: $354.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $200,598.75 |
| Royalty Or License | $75,925.58 |
| Travel and Lodging | $28,605.58 |
| Food and Beverage | $3,256.35 |
| Long Term Medical Supply Or Device Loan | $354.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $2,005,900.14 | 2019-2025 | Portfolio, Grappler, Phantom Fibula Nail |
| Avitus Orthopaedics, INC. | $49,095.20 | 2019-2023 | |
| Zimmer Biomet Holdings, INC. | $20,524.98 | 2019-2025 | Dragonwing, Avitus Bone Harvester, Archimis |
| Wright Medical Technology, INC. | $19,264.97 | 2019 | |
| Anika Therapeutics, INC. | $17,801.84 | 2020-2022 | |
| Southern Edge Orthopaedics, INC. | $3,562.43 | 2019-2023 | |
| Arthrex, INC. | $1,538.01 | 2019-2020 | |
| Citieffe, INC. | $460.00 | 2024 | |
| Ossio INC | $411.95 | 2021-2023 | |
| Stryker Corporation | $392.98 | 2023-2025 | Infinity Adaptis, Inbone, N/A |
| Integra Lifesciences Corporation | $376.91 | 2022-2025 | Acell, Tenoglide |
| Uoc USA INC | $187.76 | 2025 | U-Star, Conformity, U2 |
| Think Surgical, INC. | $148.00 | 2024 | |
| Smith+Nephew, INC. | $90.55 | 2022-2025 | Pico 14, Renasys Touch |
| Additive Orthopaedics, LLC | $70.04 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Djo, LLC | $51.24 | 2020-2024 | Cmf |
| Bone Support INC. | $50.37 | 2024 | Ceramentbone Void Filler, Cerament G |
| Fidia Pharma USA INC. | $21.42 | 2025 | Hymovis |
| Bioventus LLC | $14.40 | 2023 | Exogen Ultrasound Bone Healing System |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$13,603,883.84 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Sangiovanni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.